Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


01 junio 2013

FDA approves Kcentra for urgent warfarin reversal in patients with acute major bleeding

Vascular News

On 30 April, the FDA approved CSL Behring’s Kcentra (Prothrombin complex concentrate [human]), the first non-activated 4-factor prothrombin complex concentrate for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (eg. warfarin) therapy in adult patients with acute major bleeding.

19 marzo 2013

Por cada 10 minutos de retraso en la angioplastia, la mortalidad del infarto se incrementa en un 10%.

Noticias Médicas

Una nueva forma de abordar el infarto agudo de miocardio (IAM) en sus primeros momentos basada en estudios realizados por investigadores españoles de la ahora denominada RIC (Red de Investigación Cardiovascular) fue presentada hace meses y recomendada por las Guías de Actuación en IAM de la Sociedad Europea de Cardiología y American College of Cardiology/American Heart Association.

11 abril 2013

SynCardia certified centres to present Total Artificial Heart abstracts at International Society for Heart & Lung Transplantation

Cardiovascular News

SynCardia Systems has announced that more than 20 SynCardia certified centres representing four countries and more than 70 authors will present a record number of abstracts discussing the SynCardia temporary Total Artificial Heart at the annual meeting of the International Society for Heart & Lung Transplantation (ISHLT; Montreal, Canada, 24–27 April).

11 abril 2013

Maquet’s Air-Band Radial Compression Device Approved in United States and Europe

Endovascular Today

Maquet Cardiovascular LLC (Wayne, NJ) announced that it has received the US Food and Drug Administration’s 510(k) clearance and European CE Mark approval for the Air-Band radial compression device. The Air-Band device is indicated to assist hemostasis of the radial artery after a transradial procedure. It is designed to compress the radial artery puncture site while maintaining site visibility and a secure fit around the wrist. The Air-Band radial compression device is now commercially available in Europe and will be launched in the United States later this month.

95 2913

Caminar a paso vivo iguala a correr para la salud cardiaca

HealthDay News

Caminar a paso vivo es igual de bueno que correr para reducir la presión arterial, el colesterol y el riesgo de diabetes, tres factores importantes en el desarrollo de la enfermedad cardiaca, halla un estudio reciente.

28 marzo 2013

Left ventricular assist devices do not improve sexual function

Cardiovascular News

A study published ahead of print in the Journal of the American College of Cardiology indicates that following implantation of a left ventricular assist device (LVAD), sexual function does not improve and may even worsen—with LVAD equipment frequently cited as an obstacle to sexual function.

13 marzo 2013

Transcatheter aortic valve still works after three years in high-risk patients

Cardiovascular News

The PARTNER cohort A study, which compared transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement in high-risk patients with severe aortic stenosis, found that after three years, the valve did not show any signs of structural deterioration and that TAVI is comparable to surgery.

18 marzo 2013

ORBIT II trial meets its primary endpoint

Cardiovascular News

ORBIT III, which was presented at the recent ACC meeting, met its primary endpoint and showed that the Orbital atherectomy system (Cardiovascular Systems) was associated with an 89.8% freedom from major adverse cardiovascular events (MACE) rate and a procedural success rate of 89.1% (including in-hospital MACE).

18 marzo 2013

First-in-world implantation of next-generation Promus Premier stent

Cardiovascular News

Boston Scientific has announced that, for the first time in the world, its next generation Promus Premier everolimus-eluting stent has been implanted (at centres in Ireland and The Netherlands) in patients with coronary artery disease.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.